Filter search criteria using below inputs
Click on magnifying glass icon to search
Company | Country | Symbol |
---|
Time | Volume | SPRC |
---|---|---|
09:32 ET | 1066 | 1.23 |
09:36 ET | 100 | 1.2244 |
09:43 ET | 1300 | 1.22 |
09:45 ET | 7655 | 1.18 |
09:48 ET | 909 | 1.21 |
09:50 ET | 1000 | 1.185 |
09:52 ET | 409 | 1.2 |
09:54 ET | 110 | 1.19 |
09:56 ET | 400 | 1.1908 |
09:57 ET | 500 | 1.19 |
09:59 ET | 188 | 1.2 |
10:01 ET | 645 | 1.2 |
10:03 ET | 616 | 1.2 |
10:06 ET | 100 | 1.2 |
10:10 ET | 600 | 1.21 |
10:12 ET | 3100 | 1.24 |
10:14 ET | 3000 | 1.18 |
10:19 ET | 100 | 1.1801 |
10:32 ET | 100 | 1.2 |
10:33 ET | 200 | 1.2099 |
10:35 ET | 100 | 1.2001 |
10:39 ET | 1213 | 1.205 |
10:42 ET | 5460 | 1.21 |
10:44 ET | 1000 | 1.22 |
11:02 ET | 2400 | 1.2 |
11:13 ET | 100 | 1.2 |
11:26 ET | 4090 | 1.21 |
11:36 ET | 387 | 1.1912 |
11:47 ET | 280 | 1.21 |
12:18 ET | 350 | 1.1901 |
12:38 ET | 368 | 1.21 |
12:43 ET | 1325 | 1.2099 |
01:06 ET | 2397 | 1.2 |
01:08 ET | 318 | 1.2 |
01:10 ET | 3000 | 1.1918 |
01:14 ET | 823 | 1.2091 |
01:24 ET | 1000 | 1.2 |
01:35 ET | 100 | 1.205 |
01:37 ET | 2302 | 1.21 |
02:06 ET | 200 | 1.201 |
02:09 ET | 100 | 1.21 |
02:18 ET | 1825 | 1.22 |
02:27 ET | 500 | 1.215 |
02:29 ET | 1600 | 1.2107 |
02:31 ET | 144 | 1.22 |
02:33 ET | 356 | 1.22 |
03:02 ET | 200 | 1.218 |
03:05 ET | 1000 | 1.215 |
03:59 ET | 200 | 1.22 |
Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
---|---|---|---|
Scisparc Ltd | 3.2M | -1.0x | --- |
Americann Inc | 1.6M | -5.5x | --- |
RXElite Inc | 120.0 | 0.0x | --- |
Healthy Extracts Inc | 5.9M | -2.3x | --- |
Minerco Inc | 13.0K | 0.0x | --- |
Vapor Group Inc | 27.3K | 0.0x | --- |
Scisparc Ltd, former Therapix Biosciences Ltd is a Israel-based pharmaceutical company commited into creating and enhancing technologies and assets based on cannabinoid pharmaceuticals. The company is engaged in drug development programs based on repurposing a cannabinoid (Dronabinol): THX-110 for the treatment of Tourette syndrome (TS), for the treatment of Obstructive Sleep Apnea (OSA), and the treatment of Pain; THX-130 for the treatment of Mild Cognitive Impairment (MCI) and Traumatic Brain Injury (TBI); THX-150 for the treatment of infectious diseases; and THX-160 for the treatment of pain.
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $3.2M |
---|---|
Revenue (TTM) | $0.00 |
Shares Outstanding | 2.6M |
Dividend Yield | 0.00% |
Annual Dividend Rate | --- |
Ex-Dividend Date | 01-01-01 |
Pay Date | 01-01-01 |
Beta | --- |
EPS | $-1.22 |
Book Value | $10.77 |
P/E Ratio | -1.0x |
Price/Sales (TTM) | --- |
Price/Cash Flow (TTM) | --- |
Operating Margin | --- |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.